Psychiatr. praxi. 2012;13(2):64-68

Summary

doc.MUDr.Iva Holmerová, Ph.D.1,3, MUDr.Michaela Baumanová1, MUDr.Hana Vaňková1,3, MUDr.Božena Jurašková, Ph.D.2
1 Gerontologické centrum Praha
2 Univerzita Karlova v Praze, LF Hradec Králové, Subkatedra geriatrie
3 Univerzita Karlova v Praze, FHS, CELLO-ILC-CZ

Authors discuss pharmacotherapy of dementia caused by Alzheimer´s disease and other similar diseases. They reflect three stages of

dementia according to the strategy P-PA-IA suggested by the Czech Alzheimer Society as well as the spectrum of symptoms of this

important syndrome.

Keywords: Alzheimer´s disease, dementia, pharmacotherapy, psychosocial interventions in dementia

Published: April 23, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Holmerová I, Baumanová M, Vaňková H, Jurašková B. Summary. Psychiatr. praxi. 2012;13(2):64-68.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. World Alzheimer Report 2011. The benefits of early diagnosis and intervention. London: Alzheimer´s Disease International 2011.
    2. Global Burden of Disease. Geneve: WHO 2004. (Dostupné 10. 9. 2011 na:/www.who.int/healthinfo/global_burden_disease/cra/en/index.html).
    3. Forette F, et al. The Prevention of Dementia With Antihypertensive Treatment New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study. Arch Intern Med 2002; 162: 2046-2052. Go to original source... Go to PubMed...
    4. Mangialasche F, Solomon A, Winblad B, et al. Alzheimer´s disease: clinical trials and drug development. The Lancet Neurology 2010; 9: 702-716. Go to original source... Go to PubMed...
    5. Strategie České alzheimerovské společnosti P-PA-IA. Praha: ČALS 2008 (Dostupné 10. 9. 2011 na: http://alzheimer.cz/?PageID=629).
    6. Department of Health. Living well with dementia. A National Dementia Strategy. London> UK, Department of Health 2009.
    7. Brodaty H, Breteler MMB, DeDosky ST, et al. The World of Dementia Beyond 2010. JAGS 2011; 59(5): 923-927.
    8. Coley V, Andrieu V, Gardette V, et al. Dementia Prevention: Methodological Explanations for Inconsistent Results. Epidemiol Rev 2008; 30: 35-66. Go to original source... Go to PubMed...
    9. Wong CL, Bansback N, Lee PE, Anis AH. Cost-effectiveness: cholinesterase inhibitors and memantine in vascular dementia. Can J Neurol Sci. 2009; 36(6): 735-739. Go to original source... Go to PubMed...
    10. Kavirajan H, Schneider L. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. The Lancet Neurology 2007; 6(9): 782-792. Go to original source... Go to PubMed...
    11. Guekht AB, Moessler H, Novak PH, Gusev EI. Cerebrolysin Investigators. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial. J Stroke Cerebrovasc Dis. 2011; 20(4): 310-318. Epub 2010 Jul 24. Go to original source... Go to PubMed...
    12. Wei ZH, He QB, Wang H, Su BH, Chen HZ. Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer's disease. J Neural Transm. 2007; 114(5): 629-634. Epub 2007 Feb 23. Go to original source... Go to PubMed...
    13. Cipriani A. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009; 373: 746-758. Go to original source... Go to PubMed...
    14. Ballard C, Hanney ML, Theodoulou M, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. The Lancet Neurology 2009; 8(2): 151-157. Go to original source... Go to PubMed...
    15. Volicer L, Volicer L, Hurley A. Hospice Care for Patients with Advanced Progressive Dementia, Springer Series on Ethics, Law and Aging, New York, 1998.
    16. Moniz-Cook E, Vernooj-Dassen M, Woods T. Psychosocial Interventions in Dementia Care Research: The INTERDEM Manifesto. Aging and Mental Health, 2011; 15(3): 283-290. Go to original source... Go to PubMed...
    17. Huseboe BS, Strand LI, Moe-Nilssen R, et al. Who Suffers most? Dementia and Pain in Nursing Home Patients. A Crosssectional Study. Journal of American Medical Directors Association 2008; 9(6): 427-433. Go to original source... Go to PubMed...
    18. Holmerová I, Mátlová M, Vaňková H, et al. Demence. Med Pro Praxi 2010; 7,3: 139-144.
    19. Holmerová I, Vaňková H, Baumanová M, et al. Bolest - podceněný problém v péči o pacienty s demencí. Čes ger rev 2009; 7(1): 31-35.
    20. Gove D, Sparr S, Dos Santos Bernardo AM, et al. Recommendations on end-of-life care for people with dementia. J Nutr Health Aging 2010; 14(2): 136-139. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.